Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Biofrontera Inc. Warrants
BFRIW | US
0.07
USD0.02
60.19%
BFRIW | US
About Biofrontera Inc. Warrants
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
30/06/2024
As of date
06/03/2026
Close
0.07
Open
0.07
High
0.07
Low
0.07
Biofrontera Inc. a biopharmaceutical company develops and provides dermatological products for the treatment of skin diseases in the United States. It primarily develops therapies for non-melanoma skin cancer. It offers Ameluz an aminolevulinic acid hydrochloride gel for the photodynamic therapy of actinic keratoses; and BF-RhodoLED an LED lamp emitting red light for use in photodynamic therapy. The company was founded in 1997 and is based in Woburn Massachusetts.
View LessBFRIW | US
Risk
276.9
Sharpe
-0.06
Luna's Score
58/100
Recommendation
Hold
Luna says (BFRIW | US)
What's Working
Positive Momentum
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
What's not Working
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
276.9%1 month
276.9%3 months
361.9%6 months
286.8%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
-
Debt to equity
0.13
Debt to assets
0.07
Ent. to EBITDA
-
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-18.32M
MarketCap
-
MarketCap(USD)
-
Div. yield
-
Op. margin
-64.69
Erngs. growth
-
Rev. growth
34.00
Ret. on equity
-149.41
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.03
Range1M
0.03
Range3M
0.06
Volumes: Market Activity
Rel. volume
0.87
Price X volume
38.21
